Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Larry Wayne Hertel is active.

Publication


Featured researches published by Larry Wayne Hertel.


Bioorganic & Medicinal Chemistry Letters | 2003

Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 3

Kumiko Takeuchi; Todd J. Kohn; Nicholas Allan Honigschmidt; Vincent Patrick Rocco; Patrick Gianpietro Spinazze; Daniel James Koch; Steven T Atkinson; Larry Wayne Hertel; David L. Nelson; D.Bradley Wainscott; Laura J Ahmad; Janice Shaw; David T. Wong

A series of 1-aryloxy-3-piperidinylpropan-2-ols possessing potent dual 5-HT(1A) receptor antagonism and serotonin reuptake inhibition was discovered. 1-(1H-Indol-4-yloxy)-3-(4-benzo[b]thiophen-2-ylpiperidinyl)propan-2-ols exhibited selective and high affinity at the 5-HT(1A) receptor and serotonin reuptake inhibition at nanomolar concentrations for dual activities.


Synthetic Communications | 1991

Preparation and Storage of (R)-2,3-O-Isopropylideneglyceraldehyde (D-Glyceraldehyde Acetonide)

Larry Wayne Hertel; Cora Sue Grossman; Julian Stanley Kroin

Abstract This is a report on the synthesis and on the storage of D-glyceraldehyde acetonide for as long as three years after initial preparation while retaining its enantiomeric purity.


Cancer Research | 1991

Action of 2′,2′-Difluorodeoxycytidine on DNA Synthesis

Peng Huang; Sherri Chubb; Larry Wayne Hertel; Gerald B. Grindey; William Plunkett


Cancer Research | 1988

Comparison of the Cellular Pharmacokinetics and Toxicity of 2′,2′-Difluorodeoxycytidine and 1-β-d-Arabinofuranosylcytosine

Volker Heinemann; Larry Wayne Hertel; Gerald B. Grindey; William Plunkett


International Journal of Radiation Oncology Biology Physics | 1996

Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine

Theodore S. Lawrence; Emily Y. Chang; Tina M. Hahn; Larry Wayne Hertel; Donna S. Shewach


Cancer Research | 1992

Cellular Elimination of 2′,2′-Difluorodeoxycytidine 5′-Triphosphate: A Mechanism of Self-Potentiation

Volker Heinemann; Yi-Zheng Xu; Sherri Chubb; Alina Sen; Larry Wayne Hertel; Gerald B. Grindey; William Plunkett


Cancer Research | 1994

Metabolism of 2′,2′-Difluoro-2′-Deoxycytidine and Radiation Sensitization of Human Colon Carcinoma Cells

Donna S. Shewach; Tina M. Hahn; Emily Y. Chang; Larry Wayne Hertel; Theodore S. Lawrence


Archive | 1987

Difluoro antivirals and intermediate therefor

Larry Wayne Hertel


Archive | 1994

Method of treating tumors in mammals with 2',2'-difluoronucleosides

Gerald B. Grindey; Larry Wayne Hertel


Molecular Pharmacology | 1999

Comparison of the Mechanism of Cytotoxicity of 2-Chloro-9-(2-deoxy-2-fluoro-β-d-arabinofuranosyl)adenine, 2-Chloro-9-(2-deoxy-2-fluoro-β-d-ribofuranosyl)adenine, and 2-Chloro-9-(2-deoxy-2,2-difluoro-β-d-ribofuranosyl)adenine in CEM Cells

William B. Parker; Sue C. Shaddix; Lucy M. Rose; Donna S. Shewach; Larry Wayne Hertel; John A. Secrist; John A. Montgomery; L. Lee Bennett

Collaboration


Dive into the Larry Wayne Hertel's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

William Plunkett

University of Texas MD Anderson Cancer Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge